Results · Apr-Jun 2026 · filed 13 Aug 2026
Choksi Laboratories Q1 FY27 results
Sales grew 7% to ₹12.1 crore from ₹11.2 crore in Apr-Jun 2025.
Operating profit grew 13% to ₹3.3 crore, an operating margin of 27.2% (up 1.4 points from a year ago).
Net profit grew 51% to ₹0.58 crore from ₹0.39 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −6%, net profit −43%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 12.1 | 11.2 | +7% |
| Operating profit (EBITDA) | 3.3 | 2.9 | +13% |
| Operating margin | 27.2% | 25.8% | +1.4 pts |
| Net profit | 0.6 | 0.4 | +51% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 13 Aug 2026Submission Of Financial Results For The Quarter Ended 30Th June 2026
- 13 Aug 2026Board Meeting Outcome for Board Meeting Held On 13.08.2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.